Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $996.68 | 63 | 99.5% |
| Education | $5.00 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $252.33 | 22 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $233.08 | 10 | $0 (2017) |
| Lilly USA, LLC | $109.52 | 4 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $87.64 | 3 | $0 (2018) |
| GlaxoSmithKline, LLC. | $81.34 | 6 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $60.77 | 5 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $38.03 | 3 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $28.00 | 2 | $0 (2017) |
| Kowa Pharmaceuticals America, Inc. | $27.19 | 2 | $0 (2017) |
| PFIZER INC. | $24.15 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $13.34 | 1 | GlaxoSmithKline, LLC. ($13.34) |
| 2019 | $85.02 | 2 | Lilly USA, LLC ($74.12) |
| 2018 | $56.83 | 1 | E.R. Squibb & Sons, L.L.C. ($56.83) |
| 2017 | $846.49 | 60 | Merck Sharp & Dohme Corporation ($252.33) |
All Payment Transactions
64 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/09/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: RESPIRATORY | ||||||
| 10/02/2019 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $10.90 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/27/2019 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $74.12 | General |
| Category: Diabetes | ||||||
| 02/09/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $56.83 | General |
| Category: Cardiovascular | ||||||
| 11/02/2017 | GlaxoSmithKline, LLC. | BREO (Drug), INCRUSE | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: RESPIRATORY | ||||||
| 10/20/2017 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Diabetes | ||||||
| 10/17/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $10.88 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/09/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/04/2017 | Merck Sharp & Dohme Corporation | ASMANEX (Drug), BELSOMRA, DULERA | Food and Beverage | In-kind items and services | $6.73 | General |
| Category: RESPIRATORY | ||||||
| 09/28/2017 | GlaxoSmithKline, LLC. | BREO (Drug), INCRUSE | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: RESPIRATORY | ||||||
| 09/26/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ZOSTAVAX | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/22/2017 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $10.60 | General |
| Category: Diabetes | ||||||
| 09/19/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Education | In-kind items and services | $5.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/13/2017 | Merck Sharp & Dohme Corporation | ASMANEX (Drug), BELSOMRA, DULERA | Food and Beverage | In-kind items and services | $3.90 | General |
| Category: RESPIRATORY | ||||||
| 08/24/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/22/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: RESPIRATORY | ||||||
| 08/18/2017 | GlaxoSmithKline, LLC. | BREO (Drug), INCRUSE | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: RESPIRATORY | ||||||
| 08/15/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $4.38 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/08/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/04/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $10.42 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/31/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $4.99 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/17/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/14/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), INVOKAMET, OneTouch | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/10/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 832 | 1,459 | $182,835 | $81,077 |
| 2022 | 13 | 1,015 | 1,702 | $204,487 | $86,529 |
| 2021 | 15 | 1,053 | 1,859 | $179,481 | $84,686 |
| 2020 | 15 | 1,234 | 1,783 | $155,476 | $68,956 |
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 206 | 579 | $110,010 | $47,930 | 43.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 91 | 91 | $16,380 | $11,410 | 69.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 65 | 92 | $12,328 | $5,258 | 42.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 55 | 55 | $7,920 | $4,170 | 52.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 11 | 11 | $4,367 | $3,107 | 71.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 11 | 12 | $4,860 | $2,564 | 52.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 80 | 207 | $12,627 | $1,971 | 15.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 55 | 55 | $1,980 | $1,615 | 81.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 80 | 82 | $6,478 | $778.20 | 12.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 66 | 86 | $946.00 | $722.40 | 76.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 12 | 14 | $1,400 | $562.94 | 40.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 19 | 34 | $1,666 | $369.25 | 22.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 12 | 12 | $432.00 | $352.32 | 81.6% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 30 | 41 | $697.00 | $131.61 | 18.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 24 | 24 | $360.00 | $81.84 | 22.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 15 | 64 | $384.00 | $54.70 | 14.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 216 | 582 | $110,580 | $46,274 | 41.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 109 | 109 | $19,620 | $13,695 | 69.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 114 | 178 | $23,852 | $9,832 | 41.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 77 | 78 | $11,154 | $5,402 | 48.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 14 | 16 | $6,480 | $3,461 | 53.4% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 93 | 228 | $13,908 | $2,190 | 15.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 76 | 78 | $2,808 | $2,154 | 76.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 24 | 31 | $3,100 | $1,272 | 41.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 101 | 106 | $8,374 | $1,033 | 12.3% |
About Dr. Ramamohan Chunduri, MD
Dr. Ramamohan Chunduri, MD is a General Practice healthcare provider based in Dayton, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1598739963.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ramamohan Chunduri, MD has received a total of $1,002 in payments from pharmaceutical and medical device companies, with $13.34 received in 2023. These payments were reported across 64 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($996.68).
As a Medicare-enrolled provider, Chunduri has provided services to 4,134 Medicare beneficiaries, totaling 6,803 services with total Medicare billing of $321,249. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Practice Information
- Specialty General Practice
- Other Specialties Internal Medicine
- Location Dayton, OH
- Active Since 02/14/2006
- Last Updated 01/09/2020
- Taxonomy Code 208D00000X
- Entity Type Individual
- NPI Number 1598739963
Products in Payments
- SYMBICORT (Drug) $142.38
- JANUVIA (Drug) $131.98
- TRULICITY (Drug) $109.52
- ELIQUIS (Drug) $98.54
- DIFICID (Drug) $80.75
- FARXIGA (Drug) $79.18
- JARDIANCE (Drug) $46.72
- BREO (Drug) $41.84
- ASMANEX (Drug) $28.76
- TOUJEO (Drug) $28.00
- INVOKANA (Drug) $27.61
- Livalo (Drug) $27.19
- ANORO (Drug) $26.16
- SPIRIVA (Drug) $14.05
- TRELEGY ELLIPTA (Drug) $13.34
- CHANTIX (Drug) $13.25
- FLUZONE HIGH-DOSE (Drug) $13.16
- XIFAXAN (Drug) $12.72
- ENTRESTO (Drug) $12.05
- BEVESPI AEROSPHERE (Drug) $11.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Dayton
Dr. Jeremy Sikora, M.d, M.D
General Practice — Payments: $16,535
Robert Shelhouse, Dds, DDS
General Practice — Payments: $5,314
Mostafa Kabbani, Dds, DDS
General Practice — Payments: $4,990
Ian Rae, D.m.d, D.M.D
General Practice — Payments: $3,759
Dr. John Gazzerro, D.d.s, D.D.S
General Practice — Payments: $2,984
Dr. Sophia Thankaraj, D.d.s, D.D.S
General Practice — Payments: $1,848